{"organizations": [], "uuid": "b0aa585f2313dfa4184aab8aabe8d3c3626d9f1c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mednax-inc-reports-adjusted-eps-of/brief-mednax-inc-reports-adjusted-eps-of-0-89-idUSL8N1S786C", "country": "US", "domain_rank": 408, "title": "BRIEF-Mednax Inc Reports Adjusted EPS Of $0.89", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T01:33:00.000+03:00", "replies_count": 0, "uuid": "b0aa585f2313dfa4184aab8aabe8d3c3626d9f1c"}, "author": "", "url": "https://www.reuters.com/article/brief-mednax-inc-reports-adjusted-eps-of/brief-mednax-inc-reports-adjusted-eps-of-0-89-idUSL8N1S786C", "ord_in_thread": 0, "title": "BRIEF-Mednax Inc Reports Adjusted EPS Of $0.89", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-mednax inc", "sentiment": "negative"}, {"name": "reuters sta", "sentiment": "negative"}, {"name": "mednax inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1 (Reuters) - MEDNAX Inc:\n* QTRLY EARNINGS PER SHARE $0.68 * MEDNAX’S NET REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 INCREASED BY 7.9 PERCENT, TO $901.9 MILLION\n* SAME-UNIT REVENUE FROM NET REIMBURSEMENT-RELATED FACTORS INCREASED BY 2.1 PERCENT FOR 2018 Q1\n* FOR 2018 Q2, EXPECTS EARNINGS PER SHARE WILL BE IN A RANGE OF $0.81 TO $0.86 PER DILUTED SHARE\n* FOR 2018 Q2 EXPECTS ADJUSTED EPS WILL BE IN A RANGE OF $1.04 TO $1.09\n* FOR 2018 Q2, MEDNAX EXPECTS THAT EBITDA GROWTH WILL BE BETWEEN ONE PERCENT AND SIX PERCENT\n* OUTLOOK ASSUMES TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED JUNE 30, 2018 WILL BE IN A RANGE OF TWO TO FOUR PERCENT\n* Q1 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $903.6 MILLION — THOMSON REUTERS I/B/E/S\n* Q2 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S Source text : [ID: bit.ly/2I72lrf ] Further company coverage:\n ", "external_links": ["https://bit.ly/2I72lrf"], "published": "2018-05-01T01:33:00.000+03:00", "crawled": "2018-05-01T02:06:58.000+03:00", "highlightTitle": ""}